Form 4 for ELAN Elanco Animal Health Inc
Accepted 2023-03-06 00:00:00 ET · period of report 2023-03-02 · accession 0001415889-23-004353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | 2023-03-02 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | A - Grant | $0.00 | +316.4K | 1.29M | +32% | $0 | |
| 2023-03-06 | 2023-03-02 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | F - Tax | $11.01 | -137.9K | 1.15M | -11% | -$1.52M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-02 | A | A | 316,386 | $0.00 | 1,291,147 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-02 | F | D | 137,882 | $11.01 | 1,153,265 | D | — | — |